Gilead Sciences Retained Earnings (Accumulated Deficit) 2010-2024 | GILD

Gilead Sciences retained earnings (accumulated deficit) for the quarter ending September 30, 2024 were $11.073B, a 30.8% decline year-over-year.

  • Gilead Sciences retained earnings (accumulated deficit) for 2023 were $16.304B, a 3.93% increase from 2022.
  • Gilead Sciences retained earnings (accumulated deficit) for 2022 were $15.687B, a 3.9% decline from 2021.
  • Gilead Sciences retained earnings (accumulated deficit) for 2021 were $16.324B, a 13.51% increase from 2020.

Gilead Sciences Retained Earnings (Accumulated Deficit) 2010-2024 | GILD

  • Gilead Sciences retained earnings (accumulated deficit) for 2023 were $16.304B, a 3.93% increase from 2022.
  • Gilead Sciences retained earnings (accumulated deficit) for 2022 were $15.687B, a 3.9% decline from 2021.
  • Gilead Sciences retained earnings (accumulated deficit) for 2021 were $16.324B, a 13.51% increase from 2020.